Ellagic Acid, a Dietary Polyphenol, Selectively Cytotoxic to HSC-2 Oral Carcinoma Cells

Jeffrey H Weisburg1, Alyssa G Schuck, Sarah E Reiss

  • 1Department of Biology, Stern College for Women, 245 Lexington Avenue, New York, NY 10016 USA. weisburg@yu.edu

Abstract

Insights

Ellagic acid, a dietary polyphenol, selectively kills oral carcinoma cells by inducing apoptosis. It demonstrates significant antioxidant and minimal pro-oxidant activity, offering potential therapeutic benefits.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Ellagic acid is a natural polyphenol found in fruits and vegetables.
  • Dietary polyphenols are known for their potential health benefits, including antioxidant and anticancer properties.

Purpose of the Study:

  • To investigate the antiproliferative and apoptotic effects of ellagic acid on oral carcinoma cells.
  • To determine the pro-oxidant and antioxidant activities of ellagic acid.
  • To assess the selective cytotoxicity of ellagic acid towards cancer cells versus normal cells.

Main Methods:

  • Neutral red cytotoxicity assay to compare cell sensitivity.
  • Ferrous ion oxidation xylenol orange assay and glutathione levels to assess pro-oxidant nature.
  • 2',7'-dichlorodihydrofluorescein diacetate staining and morphological analysis for antioxidant activity.
  • Microscopy, flow cytometry, luminescence, and immunoblotting to evaluate apoptosis.

Main Results:

  • Ellagic acid exhibited selective cytotoxicity against oral carcinoma cells (HSC-2) but not normal gingival fibroblasts.
  • Ellagic acid displayed significant antioxidant activity and minimal pro-oxidant effects.
  • Apoptosis was induced in treated carcinoma cells, evidenced by morphological changes, increased caspase 3/7 activity, and PARP cleavage.

Conclusions:

  • Ellagic acid possesses significant antioxidant properties and is selectively cytotoxic to oral carcinoma cells.
  • The compound induces apoptosis in cancer cells, suggesting a potential therapeutic role.
  • Its minimal pro-oxidant activity indicates a favorable safety profile for targeted cancer treatment.